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718 The Journal of Thoracic and CardioObjective: The objective of this study was to investigate the patency in saphenous
vein coronary bypass grafts in which the proximal anastomoses were performed
with automatic connector devices or with a traditional suture technique.
Methods: Forty-six patients underwent coronary artery bypass grafting without
cardiopulmonary bypass by using one thoracic graft and one or more saphenous vein
grafts. Grafts were attached to the aorta with a Symmetry connector (St Jude
Medical, Inc, St Paul, Minn) in 23 patients, and partial occlusion of the aorta and
sutured anastomoses were used in 23 other patients. Grafts were studied intraoper-
atively with transit time flowmetry and angiography and revised if necessary.
Angiography was repeated after 3 to 5 months.
Results: Intraoperative graft patency did not differ between the 2 groups. Follow-up
angiography demonstrated excellent thoracic graft patency. Vein graft patency
decreased to 50% in the Symmetry group, whereas it was 90% in the suture group
(P .01). Twenty-five percent of the Symmetry grafts had significant stenosis in the
connector.
Conclusion: Saphenous vein grafts anastomosed to aorta with the Symmetry prox-
imal connector have low intermediate patency compared with those with tradition-
ally sutured anastomoses. We do not recommend the routine use of this device in
coronary artery bypass operations.
Cerebrovascular accident is a serious complication of coronary arterybypass grafting (CABG).1 CABG performed without cardiopulmo-nary bypass (CPB; ie, OPCAB) appeared to cause fewer neurologicdisturbances than CABG with CPB (ONCAB).2-4 Cerebrovascularaccidents might be caused by embolization on application of thepartial occlusion clamp during construction of the proximal anas-
tomosis.5 An automatic connector not requiring clamping of the aorta might be an
important tool in preventing embolization in addition to shortening operating time.6
The purpose of this study was to evaluate graft patency and clinical outcomes in
patients operated on with the Symmetry proximal anastomotic connector (St Jude
Medical, Inc, St Paul, Minn).
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PMaterials and Methods
The study was approved by the regional ethics board and planned
with 10 to 15 pilot patients, followed by a randomized trial. After
the first postoperative angiograms showed occlusion rates that
were higher than expected, the pilot phase was extended to 23
patients, and 23 patients were included as control subjects. Forty-
six patients referred for OPCAB who required at least one saphe-
nous vein graft were included. In the first 23 patients the Symmetry
connector was used, whereas in the control group proximal anas-
tomoses were sutured with a partial occlusion clamp.
Operations
Patients underwent surgical intervention in a combined operation
and angiography suite allowing intraoperative angiography. Sur-
geons had been certified after St Jude Medical Inc’s course for the
Symmetry device and had extensive experience with both ONCAB
and OPCAB surgery.7 Procedures were performed through a me-
dian sternotomy. The left internal thoracic artery (LITA) was
harvested, and the patient was heparinized. The saphenous vein
was harvested with an open technique by a trained surgeon. The
LITA was anastomosed to the left anterior descending artery first.
Proximal anastomoses of the vein grafts were performed before the
distal arteries in both groups. The veins were mounted on the
device by the main surgeon. A correct-sized device was used
according to vein diameter. The grafts were attached laterally on
the aorta to prevent kinking. In control patients partial occlusion
clamps and standard sutured anastomoses (6-0 polypropylene su-
tures) were used. Distal anastomoses were performed with 7-0
polypropylene sutures by using Octopus mechanical stabilization
(Medtronic Inc, Minneapolis, Minn). The heart was positioned
with a deep pericardial stitch8 and suction cup–type positioners.9
Proximal and occasionally distal occlusion of the native vessel
were used to improve visibility. Intracoronary shunts were occa-
sionally used.
Anticoagulation and Platelet-active Drugs
Patients received aspirin preoperatively and postoperatively. The
heparin dose was 1 to 2 mg/kg to maintain the activated clotting
time at greater than 250 seconds. Additional heparin was given as
needed. Heparin was reversed with a protamine dose calculated to
reverse 50% of administered heparin.
Intraoperative Graft Evaluation
Grafts were examined with transit time flow measurement by using
the Butterfly Flowmeter (Medistim A/S, Oslo, Norway). Criteria
described by D’Ancona and colleagues10 were used for determin-
ing graft quality. These criteria require that a well-functioning
graft demonstrates a significant diastolic flow component and a
pulsatility index of less than 5. Occluded grafts were revised. After
closure of the chest, on-table coronary angiography was per-
formed. In the case of nonfunctioning grafts, the chest was re-
opened, and the grafts were revised.
Postoperative Follow-up and Angiography
Postoperative complications and mortality were monitored. Coro-
nary angiography was repeated at least 3 months after the opera-
tion. After studying the LITA grafts, each vein graft was selec-
tively cannulated. Grafts were evaluated and graded as open or
The Journal of Thoracioccluded. The proximal anastomoses were graded as normal or
with less than 50% stenosis (grade 0), with more than 50% stenosis
(grade 1), or occluded (grade 2).
Statistical Analysis
Data were entered in the SPSS software program (SPSS Inc,
Chicago, Ill), and numeric data were analyzed with the Mann-
Whitney test and the t test. Categoric data were analyzed by using
2 analysis.
Results
Clinical Outcomes
There were no significant differences demographically be-
tween the 2 groups (Table 1). There was no operative
mortality. Two patients in the Symmetry group died after 3
months: one died from mediastinitis, and another died sud-
denly at home. None of them underwent postoperative an-
giography. There were no deaths in the control group. No
perioperative infarctions or cerebrovascular accidents were
recorded in either group, nor did any patients report typical
anginal symptoms at the time of follow-up.
Intraoperative Graft Patency
All grafts were patent, as determined by means of flow
measurement, before chest closure. Five grafts were revised
on the basis of flow (2 Symmetry and 3 control grafts). The
reason for revision was the distal anastomosis (n  3), an
overly long graft (n  1), and stenosis in the vein body (n
 1).
Angiographic patency of the LITA grafts intraopera-
tively was 100%. Three vein grafts were revised on the basis
of intraoperative angiography. One Symmetry and one con-
trol graft were corrected because of kinking, and one control
graft was corrected because of occlusion of the distal anas-
tomosis. One Symmetry graft was occluded distally but not
corrected because of a poor distal vessel. Therefore after
revision, all control grafts studied by means of angiography
were open, whereas one vein graft in the Symmetry group
Table 1. Patient characteristics
Symmetry group Control group
P
value
N 23 23
Age (y) 64.9 12 64.7 8.7 .61
Female sex 3 2 .63
LVEF 66 14 63 15 .75
Diabetes 3 3 1.00
Hypertension 10 13 .295
Previous PCI 2 1 .34
COPD 2 2 .8922
LVEF, Left ventricular ejection fraction; PCI, percutanous coronary inter-
vention; COPD, chronic obstructive pulmonary disease.remained occluded.
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Patency results are shown in Table 2 as the number of grafts
and as a percentage of studied grafts. Mean time between
the operation and angiography was 4.8  2.4 months in the
Symmetry group and 3.8 0.9 months in the control group.
The difference was not statistically significant. The LITA
had excellent patency at both time points. Vein grafts had
similar patency intraoperatively in both groups, but half of
the Symmetry grafts were occluded postoperatively, and an
additional 25% had intraconnector stenosis. In the control
group 11% of the grafts were occluded at follow-up angiog-
raphy, and only a single graft had stenosis in the proximal
anastomosis.
Five patients receiving Symmetry grafts have subse-
quently undergone reintervention as a result of the angio-
graphic findings of critical stenosis in the connector. One
control patient underwent reintervention.
Discussion
CABG continues to be a major treatment modality for
patients with coronary artery disease. The interest for mak-
ing the procedure less invasive is intense, and efforts are
made to eliminate CPB and minimize surgical incisions in
the hope of reducing stroke rates and other complications.11
Embolization of atherosclerotic debris during manipula-
tion and partial occlusion of the ascending aorta is an
important cause of cerebrovascular accidents.12,13 No-
clamp techniques for construction of the proximal anasto-
moses have been described by Robicsek.14 The Symmetry
connector appeared to be an ideal solution for the construc-
tion of no-clamp proximal anastomoses requiring minimal
manipulation of the aorta, making the construction safe,
quick, and simple. Early reports were encouraging.6 Unfor-
tunately, the clinical testing has been limited and sometimes
without angiographic follow-up.15 Clinical follow-up is not
adequate because patients with occluded vein grafts might
be asymptomatic. In other reports angiographic studies were
Table 2. Summary of postoperative angiography findings
Symmetry
group
Control
group P value
LITA total 22 23 NS
LITA studied 19 22 NS
LITA occluded 1 0 NS
Patent LITA 94.5% 100% NS
Vein graft total 43 41 NS
Vein graft studied 32 40 .09
Patent 16 36 .01
Grade 0 8 35 .01
Grade 1 8 1 .05
Grade 2 16 4 .01
LITA, Left internal thoracic artery.performed in symptomatic patients.16-18 Traverse and co-
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in 12 and occlusion in 6. Cavendish and associates17 and
Reutebuch and colleagues18 found a high incidence of ste-
nosis in symptomatic patients. Antona and coworkers19
described early angiographic patency of 94.7%, but these
angiograms were performed early postoperatively and
might correspond better with intraoperative than with post-
operative angiographic patency. Katariya and associates20
studied 32.6% of their patients after 3 months, showing 11%
occlusions and 5% stenosis in the connector.
In previous studies from our center, both intraoperative
and postoperative angiography were performed,7 demon-
strating excellent on-table vein graft patency, with a de-
crease of 10% to 15% by 3 months. In the present study vein
grafts in the control subjects behaved similarly, whereas in
the Symmetry group grafts showed occlusion and stenosis at
a much higher rate.
We have no definite explanation for the high occlusion
rate in patients receiving Symmetry grafts. Because the
connector is produced from a nitinol alloy directly exposed
to blood, both acute thrombosis and stenosis from neointi-
mal hyperplasia21 might be possible, as in coronary stents.
Autopsy reports by Katariya and associates20 and Donsky
and colleagues22 demonstrated acute thrombosis within the
device. We cannot determine whether total occlusions were
caused by primary thrombosis or thrombosis in an already
stenosed graft. The findings in the connectors with grade 1
stenosis might well be explained by neointimal hyperplasia.
Traverse and coworkers16 observed that connector stenosis
treated with stenting had a 64% recurrence rate, indicating
an active process in the anastomoses. Cavendish and asso-
ciates17 demonstrated evidence of neointimal hyperplasia
by means of intracoronary ultrasonography. Mechanical
factors might be of importance because the vein graft con-
nected with Symmetry takes off from the aorta at a 90°
angle,23 although studies have indicated that a 90° takeoff
might be hemodynamically beneficial. However, this angle
predisposes to kinking if placement on the aorta or length of
the conduit is not perfect. With the present model, proximal
anastomosis is performed first, whereas most surgeons pre-
fer to do distal anastomoses first to more easily assess graft
length. This variable was eliminated in our study because
the proximal anastomoses were always performed first.
OPCAB might require a different approach to anticoag-
ulation, platelet-active drugs, or both.24,25 Our study7 com-
paring OPCAB and ONCAB did not demonstrate different
graft patency, whereas Khan and associates26 showed lower
patency in OPCAB. Wiklund and colleagues27 reported
patency of 90% with Symmetry connectors in a small study
using CPB. Carrell and coworkers28 had no occlusions in a
group of patients undergoing ONCAB studied prospectively
but found 38% stenosis in the connector after 3 months.
Platelet damage caused by CPB might prevent acute throm-
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Pbosis in the connector but not the neointimal hyperplasia. In
our series aspirin was used routinely. Introduction of clopi-
dogrel17,23 might improve patency but could cause bleeding
or other complications.29 Further controlled studies should
be conducted before introducing clopidogrel or similar
drugs in CABG.
In conclusion, we agree that the development of connec-
tors for both proximal and distal coronary anastomosis is
warranted. Such devices might significantly decrease inva-
siveness and improve the results of CABG. More controlled
studies must be performed before the introduction of new
anastomotic devices on the market.
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Discussion
Dr John D. Puskas (Atlanta, Ga). Jacob, I enjoyed your presen-
tation very much. Congratulations on addressing an important
subject. We share—I think all of us share—your goal of reducing
aortic manipulation, and we, like you, had an initial enthusiasm for
the Symmetry device, which has waned because of problems
similar to those you have described. But not all studies have
reached these same conclusions.
There have been a total of 5 randomized studies that have not
suggested significant decreases in patency, and the St Jude man-
ufacturer will be quick to point out that they had US Food and
Drug Administration (FDA) approval and it went through the
entire approval process before getting to your hands for this study.
Therefore my question to you is as follows: What went wrong
with the post-FDA process to have this device perform as poorly
c and Cardiovascular Surgery ● Volume 128, Number 5 721
Cardiopulmonary Support and Physiology Bergsland et al
CSPin your hands as it did, and do you think that there is any difference
in the way it has performed in your study compared with in some
of the other studies on which FDA approval was based?
Dr Bergsland. This is a very good question, obviously, and my
comment, after reviewing the literature, would be that the majority
of the studies that have been performed included only clinical data,
such as absence of angina.
In some cases angiography was performed in symptomatic
patients, such as in the study by Bob Emery’s group from Minne-
apolis. When they studied the symptomatic patients, they found an
extremely high rate of occlusion and stenosis. Some of the other
studies that have shown better patency rates with Symmetry con-
nectors than we have shown have been performed after operations
with CPB. It might well be that the connectors behave differently
in CPB and in off-pump surgery because there is an element of
metal that is exposed to the blood. I think that this is a possible
mechanism. Wiklund from Sweden, for example, has performed a
controlled study with the connector, but he used CPB. The main
benefit of these devices would be in off-pump surgery.
I think that it is important that we do the right studies. I
certainly appreciate St Jude Medical’s big investment in connector
technology, but I believe we just have to design the studies a bit
differently and closer to how we are planning to use the method
clinically.
Dr Puskas. Jacob, perhaps you would comment for us about
those grafts with the Symmetry device that were open and those
that were closed. Was there any difference in terms of the partic-
ular region of the heart to which those grafts were sewn distally,
and did the size of the device used—the gray-, green-, or blue-
sized Symmetry device—have any effect on the patency? Was
there, for instance, a disproportionate number of the smaller-size
connectors that closed?
Dr Bergsland. We did not find any such evidence, but our
numbers are relatively small. We could not demonstrate any dif-
ference between the bigger and smaller devices or between grafts
to different territories.
Dr Terrence M. Yau (Toronto, Ontario, Canada). Congratu-
lations on a very provocative study. I think all of us recognize that
there are a host of technical considerations during deployment of
the Symmetry device that are quite different than what we are used
to. However, I believe that it is possible to have good results with
this device. In fact, in November, we reported in The Journal of
Thoracic and Cardiovascular Surgery a consecutive series of 27
patients in whom the patency of connector grafts constructed to the
right coronary artery territory was 100% at 1 year. Those patients
underwent on-pump operations and were maintained on no anti-
platelet therapy except aspirin.
With results as dramatic as yours, it might have been possible,
even during the course of your series, to note that things were not
going right. Did you change your technique over the course of
these 23 patients, and if so, how did you try and improve your
results?
Dr Bergsland. Obviously we got quite worried when we
started to see these results, but we discussed this at length, we had
gone through this with the ethics committee and so forth, and we
had decided that we should finish this study. I think that was
justifiable ethically; we had only 23 patients, and these could be
random changes. Therefore we did finish treating the number of
722 The Journal of Thoracic and Cardiovascular Surgery ● Novepatients that we had decided that we were going to treat. We did
not change anything during the study because it would not be
scientifically correct, such as introducing clopidogrel or other
major changes.
I want to mention one more fact that was disturbing and that we
noted in the article. The process did not seem to stop at 3 months.
Some of the grafts that were grade 1, which means 50% to 99%
stenosed at the time of restudy, showed further stenosis or occlu-
sion over the following months. Five patients in the Symmetry
group have required reintervention, including stenting of the native
vessels or stenting of the Symmetry device itself. These have been
stented with drug-eluting stents. We are going to follow these
patients further to see what will be the subsequent development.
Dr Randall K. Wolf (Cincinnati, Ohio). Jacob, I enjoyed your
presentation. I have a question for you. Given the fact that this is
a nitinol device, and, as best I can tell, it traverses the media of the
aortic wall, is it possible that in some patients’ aortas there is so
much recoil in the aorta that it closes down on this nitinol graft?
And the reason I thought of that is that there is another device that
is made of stainless steel with which the results are apparently
quite good, but that is a stronger device. What do you think about
that?
Dr Bergsland. It has been pointed out in an article by Carrel
that in the Symmetry procedure the vein is telescoped through the
hole in the aorta, and this is a big difference, of course, from the
hand-sewn anastomosis. As you point out, this device is not so
strong. This might cause the type of reaction you describe instead
of what is happening in the hand-sewn proximal anastomoses,
where the hole will open up and get bigger over time.
Dr Kit Arom (Bangkok, Thailand). I have 2 quick questions.
First, how did you bring the graft off the aorta? Second, did you
use clopidogrel after the operation?
Dr Bergsland. We started this study after we had seen some of
the preliminary reports about the Symmetry device, and we put the
device laterally on the aorta in all cases, trying to avoid the
well-known problem of kinking. Therefore we put the proximal on
the right side when we were going to the right coronary artery, and
for the other ones, we put it on the left side of the aorta.
We did not use clopidogrel in this study, except in a few
patients after the study period was over, when we saw that they had
stenosis in the connector. Otherwise, we did not use clopidogrel,
although I think it would be a logical thing to do. We would have
to study this issue in another controlled study before we could
recommend it.
Dr Robert W. Emery (St Paul, Minn). Jacob, our article in
Circulation represented the first 8 months of our experience with
this, and I think that was our learning curve. Originally, the
Symmetry device was released as a simple, quick-release, push-a-
button-and-you-are-done device, but I think there is significant
learning that goes along with this, and like you, we learned the
hard way.
Things like double loading, overloading, skiving of the aorta,
thickened aorta, and misplacement on the aorta can all lead to
stenosis, which is not really the graft’s fault. It is a technical issue
that none of us were taught and had to learn.
Did you sort of go through the same thing? Have you
developed indications and contraindications, which are most
mber 2004
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this device?
Dr Bergsland. We have not developed such recommendations.
At this time, I would only use the connector in cases in which we
truly had a very bad aorta, and I would weigh the chance of
embolization from the aorta versus the chance of losing the graft
later on. I agree that there is obviously a learning curve involved.The Journal of Thoracisurgeons from our institution in Oslo. These surgeons actually
have extensive experience in off-pump and on-pump operations
and had gone through the course offered by St Jude Medical. They
have shown their quality in many previous studies, and I think that
we see from the results with the hand-sewn anastomosis that they
know how to do these procedures. Therefore I am sorry to say that
if it is so difficult to use the device, it should not be recommended.CS
PHowever, all these operations were performed by a group of 4 It should be easier to use, not more difficult.c and Cardiovascular Surgery ● Volume 128, Number 5 723
